{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T19:46:10Z","timestamp":1795117570030,"version":"4.10.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Eye diseases and injuries impose a significant clinical problem worldwide. Safe and effective ocular drug delivery is, however, challenging due to the presence of ocular barriers. Here we report a strategy using an eye patch equipped with an array of detachable microneedles. These microneedles can penetrate the ocular surface tissue, and serve as implanted micro-reservoirs for controlled drug delivery. The biphasic drug release kinetics enabled by the double-layered micro-reservoirs largely enhances therapeutic efficacy. Using corneal neovascularization as the disease model, we show that delivery of an anti-angiogenic monoclonal antibody (DC101) by such eye patch produces ~90% reduction of neovascular area. Furthermore, quick release of an anti-inflammatory compound (diclofenac) followed by a sustained release of DC101 provides synergistic therapeutic outcome. The eye patch application is easy and minimally invasive to ensure good patient compliance. Such intraocular drug delivery strategy promises effective home-based treatment of many eye diseases.<\/jats:p>","DOI":"10.1038\/s41467-018-06981-w","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T09:12:29Z","timestamp":1539940349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":338,"title":["Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery"],"prefix":"10.1038","volume":"9","author":[{"given":"Aung","family":"Than","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan Khanh","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3358-3516","authenticated-orcid":false,"given":"Chui Ming Gemmy","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,6]]},"reference":[{"key":"6981_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau, J. W. et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35, 556\u2013564 (2012).","journal-title":"Diabetes Care"},{"key":"6981_CR2","doi-asserted-by":"publisher","first-page":"ORSF5","DOI":"10.1167\/iovs.13-12789","volume":"54","author":"R Klein","year":"2013","unstructured":"Klein, R. & Klein, B. E. The prevalence of age-related eye diseases and visual impairment in aging: current estimates. Invest. Ophthalmol. Vis. Sci. 54, ORSF5\u2013ORSF13 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"6981_CR3","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham, Y. C. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121, 2081\u20132090 (2014).","journal-title":"Ophthalmology"},{"key":"6981_CR4","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","volume":"58","author":"A Urtti","year":"2006","unstructured":"Urtti, A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv. Drug Deliv. Rev. 58, 1131\u20131135 (2006).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"6981_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.addr.2018.01.008","volume":"126","author":"A Mandal","year":"2018","unstructured":"Mandal, A. et al. Ocular delivery of proteins and peptides: challenges and novel formulation approaches. Adv. Drug Deliv. Rev. 126, 67\u201395 (2018).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"6981_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","volume":"2","author":"A Patel","year":"2013","unstructured":"Patel, A., Cholkar, K., Agrahari, V. & Mitra, A. K. Ocular drug delivery systems: an overview. World J. Pharmacol. 2, 47\u201364 (2013).","journal-title":"World J. Pharmacol."},{"key":"6981_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana, R., Ananthula, H. K., Parenky, A. & Mitra, A. K. Ocular drug delivery. AAPS J. 12, 348\u2013360 (2010).","journal-title":"AAPS J."},{"key":"6981_CR8","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2147\/OPTH.S118409","volume":"10","author":"A Farkouh","year":"2016","unstructured":"Farkouh, A., Frigo, P. & Czejka, M. Systemic side effects of eye drops: a pharmacokinetic perspective. Clin. Ophthalmol. 10, 2433\u20132441 (2016).","journal-title":"Clin. Ophthalmol."},{"key":"6981_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","volume":"27","author":"KG Falavarjani","year":"2013","unstructured":"Falavarjani, K. G. & Nguyen, Q. D. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond.) 27, 787\u2013794 (2013).","journal-title":"Eye (Lond.)"},{"key":"6981_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/eye.2011.82","volume":"25","author":"E Lavik","year":"2011","unstructured":"Lavik, E., Kuehn, M. H. & Kwon, Y. H. Novel drug delivery systems for glaucoma. Eye (Lond.) 25, 578\u2013586 (2011).","journal-title":"Eye (Lond.)"},{"key":"6981_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jconrel.2006.05.003","volume":"113","author":"C Alvarez-Lorenzo","year":"2006","unstructured":"Alvarez-Lorenzo, C., Yanez, F., Barreiro-Iglesias, R. & Concheiro, A. Imprinted soft contact lenses as norfloxacin delivery systems. J. Control. Release 113, 236\u2013244 (2006).","journal-title":"J. Control. Release"},{"key":"6981_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejpb.2017.10.016","volume":"122","author":"F Alvarez-Rivera","year":"2018","unstructured":"Alvarez-Rivera, F., Concheiro, A. & Alvarez-Lorenzo, C. Epalrestat-loaded silicone hydrogels as contact lenses to address diabetic-eye complications. Eur. J. Pharm. Biopharm. 122, 126\u2013136 (2018).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"6981_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1517\/17425247.3.2.261","volume":"3","author":"T Yasukawa","year":"2006","unstructured":"Yasukawa, T., Ogura, Y., Kimura, H., Sakurai, E. & Tabata, Y. Drug delivery from ocular implants. Expert Opin. Drug Deliv. 3, 261\u2013273 (2006).","journal-title":"Expert Opin. Drug Deliv."},{"key":"6981_CR14","doi-asserted-by":"publisher","first-page":"1700269","DOI":"10.1002\/smtd.201700269","volume":"1","author":"A Than","year":"2017","unstructured":"Than, A. et al. Transdermal delivery of anti-obesity compounds to subcutaneous adipose tissue with polymeric microneedle patches. Small Methods 1, 1700269 (2017).","journal-title":"Small Methods"},{"key":"6981_CR15","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s11095-016-1885-5","volume":"33","author":"E Larraneta","year":"2016","unstructured":"Larraneta, E., McCrudden, M. T., Courtenay, A. J. & Donnelly, R. F. Microneedles: a new frontier in nanomedicine delivery. Pharm. Res. 33, 1055\u20131073 (2016).","journal-title":"Pharm. Res."},{"key":"6981_CR16","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.biomaterials.2007.12.048","volume":"29","author":"JW Lee","year":"2008","unstructured":"Lee, J. W., Park, J. H. & Prausnitz, M. R. Dissolving microneedles for transdermal drug delivery. Biomaterials 29, 2113\u20132124 (2008).","journal-title":"Biomaterials"},{"key":"6981_CR17","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1167\/iovs.07-0066","volume":"48","author":"J Jiang","year":"2007","unstructured":"Jiang, J. et al. Coated microneedles for drug delivery to the eye. Invest. Ophthalmol. Vis. Sci. 48, 4038\u20134043 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"6981_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jconrel.2015.04.041","volume":"209","author":"HB Song","year":"2015","unstructured":"Song, H. B. et al. Impact insertion of transfer-molded microneedle for localized and minimally invasive ocular drug delivery. J. Control. Release 209, 272\u2013279 (2015).","journal-title":"J. Control. Release"},{"key":"6981_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s11095-010-0271-y","volume":"28","author":"SR Patel","year":"2011","unstructured":"Patel, S. R., Lin, A. S., Edelhauser, H. F. & Prausnitz, M. R. Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm. Res. 28, 166\u2013176 (2011).","journal-title":"Pharm. Res."},{"key":"6981_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/bjo.86.2.181","volume":"86","author":"P Aragona","year":"2002","unstructured":"Aragona, P., Papa, V., Micali, A., Santocono, M. & Milazzo, G. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br. J. Ophthalmol. 86, 181\u2013184 (2002).","journal-title":"Br. J. Ophthalmol."},{"key":"6981_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0168-3659(00)00300-X","volume":"69","author":"Y Luo","year":"2000","unstructured":"Luo, Y., Kirker, K. R. & Prestwich, G. D. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J. Control. Release 69, 169\u2013184 (2000).","journal-title":"J. Control. Release"},{"key":"6981_CR22","doi-asserted-by":"publisher","first-page":"1700307","DOI":"10.1002\/smtd.201700307","volume":"2","author":"ZY Jiang","year":"2018","unstructured":"Jiang, Z. Y. et al. Advances in stimuli\u2010responsive polypeptide nanogels. Small Methods 2, 1700307 (2018).","journal-title":"Small Methods"},{"key":"6981_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jiec.2018.05.007","volume":"65","author":"JN Zhang","year":"2018","unstructured":"Zhang, J. N., Chen, B. Z., Ashfaq, M., Zhang, X. P. & Guo, X. D. Development of a BDDE-crosslinked hyaluronic acid based microneedles patch as a dermal filler for anti-ageing treatment. J. Ind. Eng. Chem. 65, 363\u2013369 (2018).","journal-title":"J. Ind. Eng. Chem."},{"issue":"37","key":"6981_CR24","doi-asserted-by":"publisher","first-page":"1702243","DOI":"10.1002\/adma.201702243","volume":"29","author":"Hao Chang","year":"2017","unstructured":"Chang, H. et al. A swellable microneedle patch to rapidly extract skin interstitial fluid for timely metabolic analysis. Adv. Mater. 29, 1702243 (2017).","journal-title":"Advanced Materials"},{"key":"6981_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/01694243.2012.705101","volume":"27","author":"SD Gittard","year":"2013","unstructured":"Gittard, S. D. et al. The effects of geometry on skin penetration and failure of polymer microneedles. J. Adhes. Sci. Technol. 27, 227\u2013243 (2013).","journal-title":"J. Adhes. Sci. Technol."},{"key":"6981_CR26","doi-asserted-by":"publisher","first-page":"032002","DOI":"10.1088\/1748-605X\/aa92d2","volume":"13","author":"Z Chen","year":"2018","unstructured":"Chen, Z. et al. Biomaterials for corneal bioengineering. Biomed. Mater. 13, 032002 (2018).","journal-title":"Biomed. Mater."},{"key":"6981_CR27","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jbiomech.2003.12.010","volume":"37","author":"SP Davis","year":"2004","unstructured":"Davis, S. P., Landis, B. J., Adams, Z. H., Allen, M. G. & Prausnitz, M. R. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J. Biomech. 37, 1155\u20131163 (2004).","journal-title":"J. Biomech."},{"key":"6981_CR28","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/eye.2014.99","volume":"28","author":"A Matthews","year":"2014","unstructured":"Matthews, A. et al. Indentation and needle insertion properties of the human eye. Eye (Lond.) 28, 880\u2013887 (2014).","journal-title":"Eye (Lond.)"},{"key":"6981_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jmbbm.2014.09.015","volume":"40","author":"AM Romgens","year":"2014","unstructured":"Romgens, A. M., Bader, D. L., Bouwstra, J. A., Baaijens, F. P. T. & Oomens, C. W. J. Monitoring the penetration process of single microneedles with varying tip diameters. J. Mech. Behav. Biomed. Mater. 40, 397\u2013405 (2014).","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"6981_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.exer.2008.02.006","volume":"86","author":"A Elsheikh","year":"2008","unstructured":"Elsheikh, A., Alhasso, D. & Rama, P. Biomechanical properties of human and porcine corneas. Exp. Eye Res. 86, 783\u2013790 (2008).","journal-title":"Exp. Eye Res."},{"key":"6981_CR31","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1167\/iovs.15-16875","volume":"56","author":"C Labate","year":"2015","unstructured":"Labate, C. et al. Multiscale investigation of the depth-dependent mechanical anisotropy of the human corneal stroma. Invest. Ophthalmol. Vis. Sci. 56, 4053\u20134060 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"6981_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783X-17-19","volume":"17","author":"M Matthaei","year":"2012","unstructured":"Matthaei, M. et al. Systematic assessment of microneedle injection into the mouse cornea. Eur. J. Med. Res. 17, 19 (2012).","journal-title":"Eur. J. Med. Res."},{"key":"6981_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.001","volume":"49","author":"KM Meek","year":"2015","unstructured":"Meek, K. M. & Knupp, C. Corneal structure and transparency. Prog. Retin. Eye Res. 49, 1\u201316 (2015).","journal-title":"Prog. Retin. Eye Res."},{"key":"6981_CR34","doi-asserted-by":"publisher","first-page":"e0136000","DOI":"10.1371\/journal.pone.0136000","volume":"10","author":"AL Miller","year":"2015","unstructured":"Miller, A. L. & Leach, M. C. The mouse grimace scale: a clinically useful tool? PLoS One 10, e0136000 (2015).","journal-title":"PLoS One"},{"key":"6981_CR35","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya, M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2, 1097\u20131105 (2011).","journal-title":"Genes Cancer"},{"key":"6981_CR36","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/ICO.0b013e3182775f8d","volume":"32","author":"G Ferrari","year":"2013","unstructured":"Ferrari, G. et al. Topical ranibizumab as a treatment of corneal neovascularization. Cornea 32, 992\u2013997 (2013).","journal-title":"Cornea"},{"key":"6981_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","volume":"57","author":"JH Chang","year":"2012","unstructured":"Chang, J. H. et al. Corneal neovascularization: an anti-VEGF therapy review. Surv. Ophthalmol. 57, 415\u2013429 (2012).","journal-title":"Surv. Ophthalmol."},{"key":"6981_CR38","doi-asserted-by":"publisher","first-page":"17010","DOI":"10.1038\/sigtrans.2017.10","volume":"2","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. A novel peptide specifically binding to VEGF receptor suppresses angiogenesis in vitro and in vivo. Signal Transduct. Target Ther. 2, 17010 (2017).","journal-title":"Signal Transduct. Target Ther."},{"key":"6981_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nm.1985","volume":"15","author":"WW Kilarski","year":"2009","unstructured":"Kilarski, W. W., Samolov, B., Petersson, L., Kvanta, A. & Gerwins, P. Biomechanical regulation of blood vessel growth during tissue vascularization. Nat. Med. 15, 657\u2013664 (2009).","journal-title":"Nat. Med."},{"key":"6981_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1590\/S0001-37652007000300004","volume":"79","author":"LF Barros","year":"2007","unstructured":"Barros, L. F. & Belfort, R. Jr. The effects of the subconjunctival injection of bevacizumab (Avastin) on angiogenesis in the rat cornea. An. Acad. Bras. Cienc. 79, 389\u2013394 (2007).","journal-title":"An. Acad. Bras. Cienc."},{"issue":"5","key":"6981_CR41","doi-asserted-by":"publisher","first-page":"e36451","DOI":"10.1371\/journal.pone.0036451","volume":"7","author":"Nadia Zakaria","year":"2012","unstructured":"Zakaria, N. et al. Human tears reveal insights into corneal neovascularization. PLoS One 7, e36451 (2012).","journal-title":"PLoS ONE"},{"key":"6981_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1600-0420.2007.01049.x","volume":"86","author":"E Yoeruek","year":"2008","unstructured":"Yoeruek, E. et al. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. Acta Ophthalmol. 86, 322\u2013328 (2008).","journal-title":"Acta Ophthalmol."},{"key":"6981_CR43","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1021\/nn506599f","volume":"9","author":"X Yuan","year":"2015","unstructured":"Yuan, X. et al. Ocular drug delivery nanowafer with enhanced therapeutic efficacy. ACS Nano 9, 1749\u20131758 (2015).","journal-title":"ACS Nano"},{"key":"6981_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","volume":"246","author":"F Bock","year":"2008","unstructured":"Bock, F., Konig, Y., Kruse, F., Baier, M. & Cursiefen, C. Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch. Clin. Exp. Ophthalmol. 246, 281\u2013284 (2008).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"6981_CR45","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1167\/iovs.08-2941","volume":"50","author":"JT Henriksson","year":"2009","unstructured":"Henriksson, J. T., McDermott, A. M. & Bergmanson, J. P. Dimensions and morphology of the cornea in three strains of mice. Invest. Ophthalmol. Vis. Sci. 50, 3648\u20133654 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"6981_CR46","doi-asserted-by":"publisher","first-page":"1700147","DOI":"10.1002\/smtd.201700147","volume":"1","author":"J Zhuang","year":"2017","unstructured":"Zhuang, J., Fand, R. H. & Zhang, L. F. Preparation of particulate polymeric therapeutics for medical applications. Small Methods 1, 1700147 (2017).","journal-title":"Small Methods"},{"key":"6981_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.12824","volume":"1358","author":"SM Whitcup","year":"2015","unstructured":"Whitcup, S. M. & Robinson, M. R. Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis. Ann. N. Y. Acad. Sci. 1358, 1\u201312 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"6981_CR48","first-page":"1891","volume":"8","author":"RJ Barry","year":"2014","unstructured":"Barry, R. J., Nguyen, Q. D., Lee, R. W., Murray, P. I. & Denniston, A. K. Pharmacotherapy for uveitis: current management and emerging therapy. Clin. Ophthalmol. 8, 1891\u20131911 (2014).","journal-title":"Clin. Ophthalmol."},{"key":"6981_CR49","first-page":"1676","volume":"9","author":"J Wu","year":"2016","unstructured":"Wu, J., Zhang, W. S., Zhao, J. & Zhou, H. Y. Review of clinical and basic approaches of fungal keratitis. Int. J. Ophthalmol. 9, 1676\u20131683 (2016).","journal-title":"Int. J. Ophthalmol."},{"key":"6981_CR50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000357979","volume":"232","author":"N Sorkin","year":"2014","unstructured":"Sorkin, N. & Varssano, D. Corneal collagen crosslinking: a systematic review. Ophthalmologica 232, 10\u201327 (2014).","journal-title":"Ophthalmologica"},{"key":"6981_CR51","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/nprot.2007.368","volume":"2","author":"MS Rogers","year":"2007","unstructured":"Rogers, M. S., Birsner, A. E. & D\u2019Amato, R. J. The mouse cornea micropocket angiogenesis assay. Nat. Protoc. 2, 2545\u20132550 (2007).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06981-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06981-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06981-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T19:38:40Z","timestamp":1671565120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06981-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,6]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["6981"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-06981-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,6]]},"assertion":[{"value":"27 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4433"}}